Taking Diabetes to Heart: Value of Cardiovascular Biomarkers for your Diabetic Patients

Friday, 21st October 2022

13:30 – 14:30 (GMT +8)

View other time zones

At the heart of the discussion on diabetes, this webinar will discuss the importance of cardiovascular risk assessment for your type 2 diabetes mellitus patients. With the new tools on assessment, we will have a heart-to-heart talk with the experts and share how the biomarker keeps the beat.

Let’s register and find out during the webinar.

Faculty

Moderator

Dr Bee Yong Mong

Head and Senior Consultant, Department of Endocrinology, Singapore General Hospital Clinical Associate Professor, Duke-NUS Medical School

Read More

Dr. Bee Yong Mong is Head and Senior Consultant in the Department of Endocrinology, Singapore General Hospital (SGH) and Clinical Associate Professor at the Duke-NUS Medical School, Singapore. He is also the Vice President of Diabetes Singapore (DS). Dr. Bee has active research programmes around diabetes prevention, risk prediction of diabetic complications and artificial intelligence/machine learning in diabetes care. He is the Principal Investigator of the A*STAR-funded Diabetes Clinic of the Future programme, which aims to develop solutions using big data analytics, behavioural economics and digital technology to personalise care and improve outcomes among the multi-ethnic diabetes population in Singapore.

Speaker

Prof Jonathan Shaw

Deputy Director at Melbourne’s Baker Heart and Diabetes Institute

Read More

Professor Jonathan Shaw is Deputy Director at Melbourne’s Baker Heart and Diabetes Institute, where his research focuses on epidemiology and clinical research in diabetes, and he is also a consultant physician in the diabetes services. In 2014, he was included in the Thomson Reuters The World’s Most Influential Scientific Minds, which listed the 1% most highly cited scientists in the world. In 2017 and 2018, he was included in the Clarivate list of the world’s most Highly Cited Researchers. In 2020, he was listed in the Stanford University listing of the world’s top 2% of researchers.

Speaker

Dr Francis CC Chow

Consultant Endocrinologist & Honorary Associate Professor Department of Medicine & Therapeutics Prince of Wales Hospital The Chinese University of Hong Kong

Chairman & Managing Director, Hong Kong Diabetes Specialist Centre Hong Kong SAR

Read More

Dr Francis C.C. Chow is a Consultant Endocrinologist and Honorary Associate Professor at the Chinese University of Hong Kong. He has retired from his positions as Chief of the Service of the Department of Medicine and Therapeutics, Prince of Wales Hospital, and the Co-Director of the CUHK-PWH Diabetes and Endocrine Centre, an IDF Centre of Education, since June 2018. He is currently Chairman & Managing Director of the Hong Kong Diabetes Specialist Centre and is also President of the Hong Kong Association for the Study of Obesity.

Dr Chow has participated as a principal investigator in clinical trials for insulin aspart, biaspart, insulin degludec, insulin detemir, iDegLira, liraglutide and semaglutide. He has been the national principal investigator of more than 40 multi-national, multi-centre phase II and III clinical trials since 1998, including NAVIGATOR, CAROLINA, EXAMINE, BEGIN, BOOST, SCALE, SUSTAIN, PIONEER and SOUL. Over the years, he has published extensively, and is the leading author and co-author of over 200 publications of original research and reviews in peer-reviewed international journals. His research interests include epidemiology and treatment modalities in diabetes, obesity, thyroid disorders and pituitary disease.

Agenda